Search - tctmd.com

Displaying 781 - 800 of 1160

Sort: Relevancy | Date

News Daily News

Surviving CVD: Obesity Offers No Protection for Those With New Onset Cardiac Events

Michael O'Riordan

December 07, 2017

News Daily News

Diabetes Remission Possible With Significant Weight Loss: DiRECT

Michael O'Riordan

December 05, 2017

News Daily News

It’s Official: Evolocumab Gains Claim for CVD Event Reduction

Michael O'Riordan

December 04, 2017

News Daily News

FDA Approves EluNIR Drug-Eluting Stent

Michael O'Riordan

November 30, 2017

News Daily News

Genetic Study Hints at Role of Lipids in AAA Risk

Michael O'Riordan

November 30, 2017

News Daily News

Biotin Supplements Can Interfere With Cardiac Troponin Tests: FDA

Michael O'Riordan

November 28, 2017

News Daily News

Radial Access Best for PCI Following Thrombolysis in STEMI

Michael O'Riordan

November 27, 2017

News Daily News

Perfect Timing? Afternoon Valve Surgeries Have Fewer Complications

Michael O'Riordan

October 27, 2017

News Daily News

Lp(a) Not Associated With Adverse Cardiovascular Events in ACS Patients

Michael O'Riordan

October 26, 2017

News Daily News

Statins and Diabetes: Causal Link Reinforced in New Analysis

Michael O'Riordan

October 25, 2017

News Daily News

More CVD and Stroke Drive Shorter Life Spans in African-Americans: AHA

Michael O'Riordan

October 24, 2017

News Daily News

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

Michael O'Riordan

October 20, 2017

News Daily News

Evolocumab ‘Abjectly Fails’ Another Financial Stress Test

Michael O'Riordan

October 19, 2017

News Daily News

DOACs Not Associated With Major Bleeding, Mortality: Observational Analysis

Michael O'Riordan

October 19, 2017

News Daily News

Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond

Michael O'Riordan

October 17, 2017

News Daily News

Merck Calls Quits on CETP Inhibitor Anacetrapib

Michael O'Riordan

October 12, 2017

News Daily News

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Michael O'Riordan

October 11, 2017

News Daily News

Alirocumab Ban Reversed, New Trial Ordered in PCSK9 Patent Dispute

Michael O'Riordan

October 10, 2017

News Daily News

NOAC Bleeding Risk Rises With Several Drug Combinations

Michael O'Riordan

October 06, 2017

News Daily News

CTA Reduces MI Compared With Functional Stress Testing, but at a Cost

Michael O'Riordan

October 05, 2017

Advertisement

Surviving CVD: Obesity Offers No Protection for Those With New Onset Cardiac Events

Diabetes Remission Possible With Significant Weight Loss: DiRECT

It’s Official: Evolocumab Gains Claim for CVD Event Reduction

FDA Approves EluNIR Drug-Eluting Stent

Genetic Study Hints at Role of Lipids in AAA Risk

Biotin Supplements Can Interfere With Cardiac Troponin Tests: FDA

Radial Access Best for PCI Following Thrombolysis in STEMI

Perfect Timing? Afternoon Valve Surgeries Have Fewer Complications

Lp(a) Not Associated With Adverse Cardiovascular Events in ACS Patients

Statins and Diabetes: Causal Link Reinforced in New Analysis

More CVD and Stroke Drive Shorter Life Spans in African-Americans: AHA

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

Evolocumab ‘Abjectly Fails’ Another Financial Stress Test

DOACs Not Associated With Major Bleeding, Mortality: Observational Analysis

Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond

Merck Calls Quits on CETP Inhibitor Anacetrapib

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Alirocumab Ban Reversed, New Trial Ordered in PCSK9 Patent Dispute

NOAC Bleeding Risk Rises With Several Drug Combinations

CTA Reduces MI Compared With Functional Stress Testing, but at a Cost

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content